Table 3.

Effect of polyherbal formulation on lipid profile

Group	TGs (mg/dl)	TC (mg/dl)	HDL (mg/dl)	VLDL (mg/dl)	LDL (mg/dl)
NC	69.4±0.647	87.0±3.06	28.6±1.23	13.8±0.118	38.5±1.92
DNC	175±1.21**	196.0±6.64**	18.4±0.30**	34.8±0.393**	143±4.37**
DN + test 1	132±1.16##	87.3±2.42##	21.2±0.55#	26.3±0.443##	92.46±1.20##
DN + test 2	88.1±1.74##	79.0±1.46##	24.0±0.78##	17.4±0.280##	61.7±2.50##

**P<0.01 compared with NC, ^##P<0.01 compared with DNC, ^#P<0.05 compared with DNC. All values are expressed as mean±SEM. DN rats treated with dose (250 mg/kg/orally) of formulation (DN + test 1), dose (500 mg/kg/orally) of formulation (DN + test 2), respectively. TGs=Triglycerides, TC=Total cholesterol, DN=Diabetic nephropathy, NC=Normal control, DNC=DN control, SEM=Standard error of mean, HDL=High-density lipoprotein, LDL=Low-density lipoprotein, VLDL=Very LDL